Summary of experimental treatments
| Experiment | Strain | Sex | N | Number of treatments | Circadian phase | Results |
|---|---|---|---|---|---|---|
| CNO effect | Gad-Cre;R26R-EYFP | M and F | 9 | 2 | Active | Figs. 2, 3 |
| ALM effect | Gad-Cre;R26R-EYFP | M and F | 9 | 2 | Active | Not shown |
| CNO control | C57BL/6J | M and F | 8 | 2 | Inactive | Fig. 3B |
| ALM and CNO interaction | Gad-Cre;R26R-EYFP | M and F | 10 | 4 | Inactive | Figs. 4, 5 |
| ALM and CNO interaction | Orexin-tTA (DOX+) | M | 11 | 4 | Inactive | Fig. 8C,E |
| ALM and CNO interaction | Orexin-tTA (DOX-) | M | 13 | 4 | Inactive | Fig. 8D,F |
All Gad-Cre;R26R-EYFP mice were Cre+/R26+ except one Cre+/R26- male mouse.